Skip to main content
Premium Trial:

Request an Annual Quote

Biotique Grabs Rights to DoubleTwist Software

SAN FRANCISCO, July 29 - Biotique Systems said today it has obtained worldwide exclusive rights from the University of Houston for software formerly offered by defunct bioinformatics shop DoubleTwist.

 

Biotique, of Emeryville, Calif., will now have access to the d2, d2 cluster, and CRAW software platforms that powered DoubleTwist's clustering and alignment tools. Neither the school nor Biotique disclosed the terms of the agreement.

 

"We started the process as soon as we heard DoubleTwist was closing its doors," Biotique Systems CEO Stephen Sanders told GenomeWeb in an e-mail. "We were close to the more than 30 customers for DoubleTwist's clustering and alignment tools and wanted to ensure that [the customers] received continuity for their use of this technology."

 

Sanders said the new software, which also is used as the base source code for South Africa-based Electric Genetics' STACK PACK programs, will complement Biotique's core Local Integration System platform for analyzing the human genome for drug-target discovery.

 

The d2 and CRAW software, co-developed at the University of Houston by Biotique co-founder and former DoubleTwist vice president of bioinformatics John Burke, enables clustering and alignment of mRNA and EST sequences.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.